Metis Global Partners, LLC Viatris Inc Transaction History
Metis Global Partners, LLC
- $3.25 Billion
- Q4 2024
A detailed history of Metis Global Partners, LLC transactions in Viatris Inc stock. As of the latest transaction made, Metis Global Partners, LLC holds 39,747 shares of VTRS stock, worth $426,485. This represents 0.02% of its overall portfolio holdings.
Number of Shares
39,747
Previous 38,243
3.93%
Holding current value
$426,485
Previous $444,000
11.26%
% of portfolio
0.02%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding VTRS
# of Institutions
1,106Shares Held
967MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA141MShares$1.51 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$994 Million0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$677 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$671 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$523 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...